{"id":"W3215173967","doi":"10.7759/cureus.19835","title":"Time to Treatment With Nivolumab or Pembrolizumab for Patients With Advanced Melanoma in Everyday Practice","year":2021,"lang":"en","type":"article","venue":"Cureus","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Victoria; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Nivolumab; Pembrolizumab; Interquartile range; Hazard ratio; Proportional hazards model; Internal medicine; Oncology; Melanoma; Survival analysis; Cohort; Cancer; Surgery; Confidence interval; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005561655,0.00009583127,0.0003013877,0.0005032308,0.0003255609,0.0006126603,0.0002780103,0.000237467,0.001914998],"category_scores_gemma":[0.004872037,0.0001050451,0.000316579,0.001011465,0.0001544965,0.000386894,0.0003823947,0.0005853569,0.0002466022],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008122807,"about_ca_system_score_gemma":0.0009376416,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006035633,"about_ca_topic_score_gemma":0.00760687,"domain_scores_codex":[0.9992919,0.0001446015,0.0001140336,0.0002047818,0.000138364,0.0001062121],"domain_scores_gemma":[0.9955728,0.0008416226,0.002813876,0.00007086067,0.0002223346,0.0004785968],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002615576,0.00007281736,0.9851092,0.00009750156,0.00005010362,0.0001519308,0.0001564194,0.0001271785,0.0002249114,0.00007186997,0.0007718197,0.01290469],"study_design_scores_gemma":[0.00003187422,0.0002659743,0.9946102,0.00008980516,0.00005338564,0.0008817847,0.0004063391,0.000680525,0.0001567013,0.0002070211,0.002607058,0.000009280669],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933919,0.002675033,0.0003037014,0.0006948865,0.00002470164,0.00002583282,0.001097083,0.00001430396,0.001772457],"genre_scores_gemma":[0.9979492,0.0008060751,0.0002628258,0.0001465528,0.00004529343,0.00002758421,0.0005446453,0.000003479157,0.0002143285],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006035633,"threshold_uncertainty_score":0.01200098,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01003157241634539,"score_gpt":0.2743858091931806,"score_spread":0.2643542367768352,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}